These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12234836)

  • 1. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
    Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.
    Furneri PM; Rappazzo G; Musumarra MP; Di Pietro P; Catania LS; Roccasalva LS
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2958-60. PubMed ID: 11557502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
    Lucier TS; Heitzman K; Liu SK; Hu PC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2770-3. PubMed ID: 8593017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Susceptibility to Macrolide-Lincosamide in Mycoplasma synoviae Is Associated with Mutations in 23S Ribosomal RNA.
    Lysnyansky I; Gerchman I; Flaminio B; Catania S
    Microb Drug Resist; 2015 Dec; 21(6):581-9. PubMed ID: 25734368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.
    Pereyre S; Guyot C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Feb; 48(2):460-5. PubMed ID: 14742195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms of macrolide resistance revealed by
    Wang N; Xu X; Xiao L; Liu Y
    Front Cell Infect Microbiol; 2023; 13():1186017. PubMed ID: 37284499
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.
    Sato T; Higuchi H; Yokota SI; Tamura Y
    Microbiol Immunol; 2017 Jun; 61(6):215-224. PubMed ID: 28504455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutant Mycoplasma hominis strains resistant to 16-membered macrolide antibiotic josamycin in clinical samples.
    Karamova AE; Polyakov AV; Komarova NV
    Bull Exp Biol Med; 2004 May; 137(5):483-4. PubMed ID: 15455124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
    Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
    FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 23S rRNA and L22 ribosomal protein are involved in the acquisition of macrolide and lincosamide resistance in Mycoplasma capricolum subsp. capricolum.
    Prats-van der Ham M; Tatay-Dualde J; Gómez-Martín Á; Corrales JC; Contreras A; Sánchez A; de la Fe C
    Vet Microbiol; 2018 Mar; 216():207-211. PubMed ID: 29519518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli.
    Ladely SR; Meinersmann RJ; Englen MD; Fedorka-Cray PJ; Harrison MA
    Foodborne Pathog Dis; 2009; 6(1):91-8. PubMed ID: 19014274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
    Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
    Halling SM; Jensen AE
    BMC Microbiol; 2006 Oct; 6():84. PubMed ID: 17014718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in
    Capitaine A; Woerther PL; Auzou M; Chachaty E; Guérin F; Giard JC; Cattoir V; Isnard C
    Microb Drug Resist; 2020 Jul; 26(7):727-731. PubMed ID: 32031922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.